Tag: evolus

April 18, 2019

Pharma Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
December 19, 2018

Evolus Added to NASDAQ Biotechnology Index

Evolus (NASDAQ:EOLS), a company dedicated to aesthetic medicine, announced that the company has been selected for addition to the NASDAQ...
August 29, 2018

Evolus Receives Acceptance of FDA BLA Resubmission for DWP-450

Evolus (NASDAQ:EOLS), a company dedicated to aesthetic medicine, today announced the acceptance of its resubmission of its Biologics License Application...
August 17, 2018

Evolus Granted Approval of DWP-450 by Health Canada

Evolus (NASDAQ:EOLS), a company dedicated to aesthetic medicine, today announced that Health Canada has granted approval of DWP-450 (prabotulinumtoxinA) for...